| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | scavenger receptor activity | 7.06e-06 | 27 | 28 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 5.28e-05 | 8 | 28 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 8.47e-05 | 10 | 28 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.26e-04 | 85 | 28 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.78e-04 | 229 | 28 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.55e-04 | 20 | 28 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.58e-03 | 42 | 28 | 2 | GO:0005109 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.73e-03 | 44 | 28 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | nuclease activity | 4.04e-03 | 231 | 28 | 3 | GO:0004518 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.08e-03 | 68 | 28 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.20e-03 | 69 | 28 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.44e-03 | 71 | 28 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 6.77e-03 | 547 | 28 | 4 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 7.07e-03 | 554 | 28 | 4 | GO:0030546 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.13e-04 | 12 | 28 | 2 | GO:0044666 | |
| Domain | FYrich_C | 2.16e-05 | 5 | 28 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.16e-05 | 5 | 28 | 2 | IPR003888 | |
| Domain | FYRC | 2.16e-05 | 5 | 28 | 2 | SM00542 | |
| Domain | FYRN | 2.16e-05 | 5 | 28 | 2 | SM00541 | |
| Domain | FYRN | 2.16e-05 | 5 | 28 | 2 | PF05964 | |
| Domain | FYRC | 2.16e-05 | 5 | 28 | 2 | PF05965 | |
| Domain | FYRC | 2.16e-05 | 5 | 28 | 2 | PS51543 | |
| Domain | FYRN | 2.16e-05 | 5 | 28 | 2 | PS51542 | |
| Domain | EGF | 2.34e-05 | 235 | 28 | 5 | SM00181 | |
| Domain | Somatomedin_B | 6.03e-05 | 8 | 28 | 2 | PF01033 | |
| Domain | SO | 7.75e-05 | 9 | 28 | 2 | SM00201 | |
| Domain | Somatomedin_B_dom | 9.68e-05 | 10 | 28 | 2 | IPR001212 | |
| Domain | SMB_1 | 9.68e-05 | 10 | 28 | 2 | PS00524 | |
| Domain | SMB_2 | 9.68e-05 | 10 | 28 | 2 | PS50958 | |
| Domain | PHD | 1.90e-04 | 75 | 28 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.21e-04 | 79 | 28 | 3 | IPR019787 | |
| Domain | Post-SET_dom | 2.57e-04 | 16 | 28 | 2 | IPR003616 | |
| Domain | PostSET | 2.57e-04 | 16 | 28 | 2 | SM00508 | |
| Domain | POST_SET | 2.57e-04 | 16 | 28 | 2 | PS50868 | |
| Domain | PHD | 3.14e-04 | 89 | 28 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.36e-04 | 91 | 28 | 3 | IPR001965 | |
| Domain | Wnt | 3.65e-04 | 19 | 28 | 2 | IPR005817 | |
| Domain | WNT1 | 3.65e-04 | 19 | 28 | 2 | SM00097 | |
| Domain | Wnt_CS | 3.65e-04 | 19 | 28 | 2 | IPR018161 | |
| Domain | wnt | 3.65e-04 | 19 | 28 | 2 | PF00110 | |
| Domain | WNT1 | 3.65e-04 | 19 | 28 | 2 | PS00246 | |
| Domain | ZF_PHD_2 | 3.81e-04 | 95 | 28 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 3.93e-04 | 96 | 28 | 3 | PS01359 | |
| Domain | EPHD | 4.91e-04 | 22 | 28 | 2 | PS51805 | |
| Domain | DHHC | 6.36e-04 | 25 | 28 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 6.36e-04 | 25 | 28 | 2 | IPR001594 | |
| Domain | Znf_FYVE_PHD | 1.35e-03 | 147 | 28 | 3 | IPR011011 | |
| Domain | VWC | 1.47e-03 | 38 | 28 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.47e-03 | 38 | 28 | 2 | PS50184 | |
| Domain | Growth_fac_rcpt_ | 1.61e-03 | 156 | 28 | 3 | IPR009030 | |
| Domain | SET | 1.71e-03 | 41 | 28 | 2 | PF00856 | |
| Domain | VWF_dom | 1.80e-03 | 42 | 28 | 2 | IPR001007 | |
| Domain | SET | 2.15e-03 | 46 | 28 | 2 | SM00317 | |
| Domain | SET_dom | 2.54e-03 | 50 | 28 | 2 | IPR001214 | |
| Domain | SET | 2.54e-03 | 50 | 28 | 2 | PS50280 | |
| Domain | HMG_box | 2.85e-03 | 53 | 28 | 2 | PF00505 | |
| Domain | HMG | 2.96e-03 | 54 | 28 | 2 | SM00398 | |
| Domain | EGF_extracell | 3.64e-03 | 60 | 28 | 2 | IPR013111 | |
| Domain | EGF_2 | 3.64e-03 | 60 | 28 | 2 | PF07974 | |
| Domain | HMG_box_dom | 4.25e-03 | 65 | 28 | 2 | IPR009071 | |
| Domain | EGF-like_dom | 6.00e-03 | 249 | 28 | 3 | IPR000742 | |
| Domain | EGF_1 | 6.40e-03 | 255 | 28 | 3 | PS00022 | |
| Domain | EGF-like_CS | 6.83e-03 | 261 | 28 | 3 | IPR013032 | |
| Domain | EGF_2 | 7.12e-03 | 265 | 28 | 3 | PS01186 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 3.56e-04 | 19 | 21 | 2 | M47836 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 6.21e-04 | 25 | 21 | 2 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 6.72e-04 | 26 | 21 | 2 | M27239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 7.81e-04 | 28 | 21 | 2 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 8.38e-04 | 29 | 21 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 8.38e-04 | 29 | 21 | 2 | M47377 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28483418 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 36869380 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28967912 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10597319 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 6.25e-07 | 2 | 28 | 2 | 34156443 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25346535 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31924266 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 27280393 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 36601880 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 21307125 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 9177220 | ||
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 1.87e-06 | 3 | 28 | 2 | 22183980 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23932714 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 21683083 | ||
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 3.75e-06 | 4 | 28 | 2 | 19221051 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 34645806 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28398509 | ||
| Pubmed | GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. | 3.75e-06 | 4 | 28 | 2 | 12478477 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24081332 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 3.75e-06 | 4 | 28 | 2 | 23129768 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16683188 | ||
| Pubmed | MLL3/MLL4-Associated PAGR1 Regulates Adipogenesis by Controlling Induction of C/EBPβ and C/EBPδ. | 6.24e-06 | 5 | 28 | 2 | 32601106 | |
| Pubmed | Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF. | 6.24e-06 | 5 | 28 | 2 | 31127101 | |
| Pubmed | The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. | 6.24e-06 | 5 | 28 | 2 | 9692890 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 26744420 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 23250740 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 9.36e-06 | 6 | 28 | 2 | 17021013 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 30604749 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 36598580 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 19556342 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 9441749 | ||
| Pubmed | 1.33e-05 | 57 | 28 | 3 | 18022353 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 30335158 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.74e-05 | 8 | 28 | 2 | 23130995 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 22266653 | ||
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 1.74e-05 | 8 | 28 | 2 | 21447625 | |
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 22665483 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 10860661 | ||
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 2.80e-05 | 10 | 28 | 2 | 16258938 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 37012455 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 15778975 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 27563068 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 4.85e-05 | 13 | 28 | 2 | 17761849 | |
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 21502505 | ||
| Pubmed | 5.65e-05 | 14 | 28 | 2 | 12482968 | ||
| Pubmed | 6.52e-05 | 15 | 28 | 2 | 17925232 | ||
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 24368734 | ||
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 8.44e-05 | 17 | 28 | 2 | 8167409 | |
| Pubmed | 8.44e-05 | 17 | 28 | 2 | 26180087 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 9.49e-05 | 18 | 28 | 2 | 17500065 | |
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 1.06e-04 | 19 | 28 | 2 | 28834739 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.18e-04 | 20 | 28 | 2 | 29785026 | |
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 19047629 | ||
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 33431871 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 1.30e-04 | 21 | 28 | 2 | 27626377 | |
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 1.30e-04 | 21 | 28 | 2 | 31914354 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 1.30e-04 | 21 | 28 | 2 | 11914369 | |
| Pubmed | 1.42e-04 | 126 | 28 | 3 | 17897319 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.43e-04 | 22 | 28 | 2 | 26886794 | |
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 27362799 | ||
| Pubmed | 2.17e-04 | 27 | 28 | 2 | 17804636 | ||
| Pubmed | 2.33e-04 | 28 | 28 | 2 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 2.33e-04 | 28 | 28 | 2 | 24394376 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 2.50e-04 | 29 | 28 | 2 | 22956684 | |
| Pubmed | 2.50e-04 | 29 | 28 | 2 | 18364260 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 2.68e-04 | 30 | 28 | 2 | 21936019 | |
| Pubmed | 2.68e-04 | 30 | 28 | 2 | 15880404 | ||
| Pubmed | 2.68e-04 | 30 | 28 | 2 | 19282366 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 2.68e-04 | 30 | 28 | 2 | 36305473 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.86e-04 | 31 | 28 | 2 | 20516061 | |
| Pubmed | MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. | 3.25e-04 | 33 | 28 | 2 | 32439762 | |
| Pubmed | 3.66e-04 | 35 | 28 | 2 | 31167144 | ||
| Pubmed | 3.66e-04 | 35 | 28 | 2 | 30940800 | ||
| Pubmed | 3.66e-04 | 35 | 28 | 2 | 23376422 | ||
| Pubmed | 3.66e-04 | 35 | 28 | 2 | 19185060 | ||
| Pubmed | Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea. | 3.66e-04 | 35 | 28 | 2 | 32907846 | |
| Pubmed | 3.87e-04 | 36 | 28 | 2 | 31604927 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 4.09e-04 | 37 | 28 | 2 | 35831952 | |
| Pubmed | 4.32e-04 | 38 | 28 | 2 | 23190887 | ||
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 4.32e-04 | 38 | 28 | 2 | 21041481 | |
| Pubmed | 4.55e-04 | 39 | 28 | 2 | 24586192 | ||
| Pubmed | 5.53e-04 | 43 | 28 | 2 | 33472061 | ||
| Pubmed | 5.79e-04 | 44 | 28 | 2 | 23884445 | ||
| Pubmed | Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. | 6.61e-04 | 47 | 28 | 2 | 16678101 | |
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 6.61e-04 | 47 | 28 | 2 | 28813421 | |
| Pubmed | 6.61e-04 | 47 | 28 | 2 | 33141892 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 7.18e-04 | 49 | 28 | 2 | 19562671 | |
| Pubmed | 7.48e-04 | 50 | 28 | 2 | 37974198 | ||
| Cytoband | 12p13 | 7.06e-04 | 64 | 28 | 2 | 12p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.14e-03 | 423 | 28 | 3 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 7.96e-03 | 220 | 28 | 2 | chr11q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q42 | 9.41e-03 | 240 | 28 | 2 | chr1q42 | |
| GeneFamily | PHD finger proteins | 1.72e-04 | 90 | 22 | 3 | 88 | |
| GeneFamily | Wnt family|Endogenous ligands | 2.39e-04 | 19 | 22 | 2 | 360 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.74e-04 | 34 | 22 | 2 | 487 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.19e-03 | 394 | 22 | 4 | 471 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-02 | 161 | 22 | 2 | 593 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.12e-05 | 140 | 28 | 3 | a88dbe7bf3e1419e360ab0b8cf24681d3424c3a7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.72e-05 | 143 | 28 | 3 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 155 | 28 | 3 | 216a240bfb82cdefc59e2f342689dbaaacb7c184 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 156 | 28 | 3 | 33deda19f06172079ef1dd49fd54d66da1e7fb14 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_TCM|Int-URO / Disease, Lineage and Cell Type | 1.31e-04 | 158 | 28 | 3 | edcc5a26d4571b179f3ae538fed23b661e4677dd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-04 | 158 | 28 | 3 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 159 | 28 | 3 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-04 | 168 | 28 | 3 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 168 | 28 | 3 | 18c266162a879544c0103d9dff0270af68964f9e | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 168 | 28 | 3 | cb1506cd43a4f36f9024cc9b8e5319365498d244 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-04 | 169 | 28 | 3 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 170 | 28 | 3 | 7040f7b1e4d8d26db787449e557371c5d872c95a | |
| ToppCell | IIH-CD8-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 1.68e-04 | 172 | 28 | 3 | 1466cb4298c63e995b3368d296b254e0e76a1b41 | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-04 | 173 | 28 | 3 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 184 | 28 | 3 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.04e-04 | 184 | 28 | 3 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 185 | 28 | 3 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 185 | 28 | 3 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 186 | 28 | 3 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 186 | 28 | 3 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 187 | 28 | 3 | 7b24a324335c30c4b37795c43611b297274c804b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 189 | 28 | 3 | cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 189 | 28 | 3 | 102501eee7760d5882dec41ea9d00147b3f4fb73 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 189 | 28 | 3 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 189 | 28 | 3 | 6e83bf855d4771885b60bb8992df2f9b508eef97 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 2.25e-04 | 190 | 28 | 3 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.25e-04 | 190 | 28 | 3 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 192 | 28 | 3 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 192 | 28 | 3 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 2.35e-04 | 193 | 28 | 3 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | normal_Lung|World / Location, Cell class and cell subclass | 2.39e-04 | 194 | 28 | 3 | affae83d7f982d18117f5b95705f09809f304b0b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-04 | 194 | 28 | 3 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 195 | 28 | 3 | 4df004b8ca7669a57d85c6dffef5b82b4ea1dfdf | |
| ToppCell | Bronchial_Biopsy-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.42e-04 | 195 | 28 | 3 | 6800c17026ec6c56132bf4664b8fcd74d7836579 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 195 | 28 | 3 | 9e49e59a20b1bbd6167d594c33ab6bdfe2c1ebaf | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 195 | 28 | 3 | 412a9fcf9f075d97fae254bbd89774e4b1face07 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 196 | 28 | 3 | 511e9846d204b2346b17d1a4142c3bb484b08e32 | |
| ToppCell | medial-2-Hematologic-Natural_Killer_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.46e-04 | 196 | 28 | 3 | c0a3749b06c47574ab252e96688aec9eea2924de | |
| ToppCell | medial-Hematologic-Natural_Killer_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.46e-04 | 196 | 28 | 3 | 6d8430ea37bb5ade25ae6b2b1a05158e72705e66 | |
| ToppCell | medial-Hematologic-Natural_Killer_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.46e-04 | 196 | 28 | 3 | 510a2359947fc6658515b363f975329697692848 | |
| ToppCell | distal-2-Hematologic-Alveolar_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.54e-04 | 198 | 28 | 3 | a8093144cbe3069c25a6c1f1c94218a115da8748 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 198 | 28 | 3 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | medial-Hematologic-Alveolar_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.54e-04 | 198 | 28 | 3 | d64f3d806594619607a72025a93b43ed4efaed01 | |
| ToppCell | control-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.54e-04 | 198 | 28 | 3 | 14bd612e9f9358ebff6cf8dda6a3165de9e4e3b0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 198 | 28 | 3 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | medial-Hematologic-Alveolar_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.54e-04 | 198 | 28 | 3 | 8a21f885d26959b349eb4ca027328d6cf0f1b9cf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 198 | 28 | 3 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 198 | 28 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | medial-2-Hematologic-Alveolar_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.54e-04 | 198 | 28 | 3 | ad8b9ac155737f794bf1974c59f8143c6ef63d71 | |
| ToppCell | 18-Distal-Immune|Distal / Age, Tissue, Lineage and Cell class | 2.54e-04 | 198 | 28 | 3 | e68d4a152f0d19fe161c75a0cb844f505b667b6b | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.57e-04 | 199 | 28 | 3 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 2.57e-04 | 199 | 28 | 3 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.57e-04 | 199 | 28 | 3 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_Tcm|Int-URO / Disease, condition lineage and cell class | 2.61e-04 | 200 | 28 | 3 | 9535fd16a962d57e80319bc26093617e04c8b2a8 | |
| ToppCell | (2)_MNPs-(2)_Mono_macro|(2)_MNPs / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.35e-04 | 64 | 28 | 2 | 494f500ccceeedf45b4ded919b237a7fb75827c4 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.29e-04 | 68 | 28 | 2 | 9ce22a6dea3c17d5352572ea0dabe6c6120b9f82 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.29e-04 | 68 | 28 | 2 | 89d337147899a978a7467db24e876a613bdd2288 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.64e-03 | 96 | 28 | 2 | bf62c29da66aa3eefdc59337dfb3cd0467f04f10 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.64e-03 | 96 | 28 | 2 | d98df92856840602a82d3f050bf0a1543445cac0 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.78e-03 | 100 | 28 | 2 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.78e-03 | 100 | 28 | 2 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.78e-03 | 100 | 28 | 2 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 103 | 28 | 2 | 39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 103 | 28 | 2 | 01a7baaa0c3903bd00e37717856d2c1ac21bf2c8 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.03e-03 | 107 | 28 | 2 | fb06b39b0f1bcb8fc8ae8ebbf2b30d6f90a1839a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-Gpr83_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.07e-03 | 108 | 28 | 2 | 5af010a1ee6535b144ccd16999c225508a4b3433 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 112 | 28 | 2 | ba0bd3a77c4865a71fb92d195cd7459c562b63db | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 112 | 28 | 2 | f9a796b4b5e227096ab360ca9ec08b1c564ac1eb | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 112 | 28 | 2 | 153614f307525af56501ac8f9c357c5f7de7882c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 113 | 28 | 2 | 6f270b7e59c18243e876311df721e948ce21e850 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-03 | 116 | 28 | 2 | 9c92e714e210a2f29a9e228653d4c990ec643c72 | |
| ToppCell | |World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-03 | 121 | 28 | 2 | da8fe561dcf50792d0cbcaad383d564f900a6677 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_A-3|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.89e-03 | 128 | 28 | 2 | f6b2be273e8b9002849fd892071a04f9fb76dc66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.94e-03 | 129 | 28 | 2 | 2f30b4897343586c9b49a1d2bec3007ec737085c | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.07e-03 | 132 | 28 | 2 | 6a6718582edfc59c63f2c8f753be81e0f4a7246b | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.07e-03 | 132 | 28 | 2 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 3.12e-03 | 133 | 28 | 2 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.16e-03 | 134 | 28 | 2 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.16e-03 | 134 | 28 | 2 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.16e-03 | 134 | 28 | 2 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.16e-03 | 134 | 28 | 2 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-03 | 135 | 28 | 2 | 1fe684ed5913ae757ad6befbbe12d1bee481dd12 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.21e-03 | 135 | 28 | 2 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 3.21e-03 | 135 | 28 | 2 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-03 | 135 | 28 | 2 | 99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-03 | 136 | 28 | 2 | b4a934feea46eeb10d407d1545bd225173078792 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-03 | 137 | 28 | 2 | 885e4cfc237eca1fa2eb1f2fd8d84f151e21ecfa | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.35e-03 | 138 | 28 | 2 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-03 | 138 | 28 | 2 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-03 | 139 | 28 | 2 | aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-03 | 139 | 28 | 2 | b9c2dfab119ac0efdf931bb2910e82bccdb4e48d | |
| ToppCell | droplet-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-03 | 140 | 28 | 2 | d91ab34d6fded8c39d0f4456ce73281334660f74 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.49e-03 | 141 | 28 | 2 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.49e-03 | 141 | 28 | 2 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | severe_COVID-19-gd_T|World / disease group, cell group and cell class (v2) | 3.49e-03 | 141 | 28 | 2 | d2575900775ce6801364c2d4eed8d213f30fa0e0 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_TCM|URO / Disease, Lineage and Cell Type | 3.49e-03 | 141 | 28 | 2 | 53aef819f505238011f8a3202445f31055791d05 | |
| ToppCell | Control-Hematopoietic_Mast-Mast_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-03 | 142 | 28 | 2 | a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd | |
| Drug | a-5a | 4.07e-05 | 8 | 28 | 2 | CID000196672 | |
| Drug | coprogen | 5.22e-05 | 9 | 28 | 2 | CID006323272 | |
| Drug | butenal | 6.67e-05 | 180 | 28 | 4 | CID000020138 | |
| Drug | AC1O6ABO | 7.97e-05 | 11 | 28 | 2 | CID006449889 | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; PC3; HT_HG-U133A | 8.22e-05 | 190 | 28 | 4 | 7301_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 8.74e-05 | 193 | 28 | 4 | 6223_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 3802_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 4634_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 7372_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 4000_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 2793_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 2810_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 7296_UP | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 2303_DN | |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 3127_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 6005_UP | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 5264_DN | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 8.06e-07 | 2 | 27 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 2.79e-04 | 27 | 27 | 2 | C0036920 | |
| Disease | mean arterial pressure, unipolar depression | 3.93e-04 | 32 | 27 | 2 | EFO_0003761, EFO_0006340 | |
| Disease | Moyamoya disease | 6.16e-04 | 40 | 27 | 2 | MONDO_0016820 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 7.79e-04 | 45 | 27 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.82e-03 | 69 | 27 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.25e-03 | 616 | 27 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.25e-03 | 616 | 27 | 4 | C0376358 | |
| Disease | lung adenocarcinoma (is_marker_for) | 2.75e-03 | 85 | 27 | 2 | DOID:3910 (is_marker_for) | |
| Disease | Squamous cell carcinoma of esophagus | 3.42e-03 | 95 | 27 | 2 | C0279626 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 3.47e-03 | 335 | 27 | 3 | EFO_0009931 | |
| Disease | Adenoid Cystic Carcinoma | 3.78e-03 | 100 | 27 | 2 | C0010606 | |
| Disease | Beta blocking agent use measurement | 4.88e-03 | 114 | 27 | 2 | EFO_0009929 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 5.65e-03 | 123 | 27 | 2 | EFO_0007789, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CAGCSSDKQQCWCRQ | 221 | Q9UJX6 | |
| NAECACRNGWQCRDK | 101 | P26842 | |
| CRNGWQCRDKECTEC | 106 | P26842 | |
| RVRDACGCCWECANL | 71 | Q96I82 | |
| GWRCLECTVCEACGK | 1001 | Q8NEZ4 | |
| CCCGDLRENFCWNLD | 306 | Q2TV78 | |
| CANSRCIQERWKCDG | 861 | Q07954 | |
| AACQCDRRCLWHGNC | 36 | P21128 | |
| QFCCCEVLGCEWEDA | 306 | O94886 | |
| RCQCFSGWEGDRCQC | 571 | P26012 | |
| RWQCIECKTCSSCRD | 256 | Q92794 | |
| DLRVWQDCCADCRSR | 1291 | A1KZ92 | |
| CCRWCCCCGERETRT | 11 | P51797 | |
| CDVACKDRGDCCWDF | 71 | O14638 | |
| ERCCWCLCCGCEVRE | 61 | Q86UT8 | |
| SCAAAKTQGRCCWEC | 186 | A6NEL2 | |
| GELVCKENDCWCKCS | 286 | Q9C0B6 | |
| DWKCDSGCVDNCTQC | 496 | O75443 | |
| CCESRCGFVCARAWT | 181 | Q8IUA0 | |
| KCTRCNAGWIGDRCE | 346 | Q96GP6 | |
| CLCDCQDLDEGCDRW | 41 | Q8IYP9 | |
| CQVRWCCYVECRQCT | 341 | O14904 | |
| SRCQNEWYCCRECQV | 406 | O75800 | |
| CQCAGMDWTGARCCR | 91 | Q9HD89 | |
| ERALCGQCVRTCWGC | 131 | O15304 | |
| DWQDQVFQFCCRDCC | 606 | Q14202 | |
| WCCAVRCKECRNTVD | 361 | Q93097 | |
| SDCCSCQEKWVGYRC | 56 | Q13241 | |
| AGWQCPECKVCQACR | 266 | O14686 |